MLN4924 (Pevonedistat), a protein neddylation inhibitor, suppresses proliferation and migration of human clear cell renal cell carcinoma

por Shuai Tong, Yang Si, Hefen Yu, Lingqiang Zhang, Ping Xie, Wenguo Jiang
Publicado 2017

Upregulate KIF4A Enhances Proliferation, Invasion of Hepatocellular Carcinoma and Indicates poor prognosis Across Human Cancer Types

por Guojun Hou, Chuanpeng Dong, Zihui Dong, Gang Liu, Huilin Xu, Lei Chen, Lei Liu, Hongyang Wang, Weiping Zhou
Publicado 2017

[65] Use of the R.E.N.A.L nephrometry score in decision making for renal cell carcinoma (RCC) treatment

por Khaled Hosny, Mohamed Aboelsoud
Publicado 2018

A Dual-Modality MR/PA Imaging Contrast Agent Based on Ultrasmall Biopolymer Nanoparticles for Orthotopic Hepatocellular Carcinoma Imaging

por Sun J, Li X, Chen A, Cai W, Peng X, Li L, Fan B, Wang L, Zhang H, Zhang R
Publicado 2019

p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming

por Tetsuya Saito, Yoshinobu Ichimura, Keiko Taguchi, Takafumi Suzuki, Tsunehiro Mizushima, Kenji Takagi, Yuki Hirose, Masayuki Nagahashi, Tetsuro Iso, Toshiaki Fukutomi, Maki Ohishi, Keiko Endo, Takefumi Uemura, Yasumasa Nishito, Shujiro Okuda, Miki Obata, Tsuguka Kouno, Riyo Imamura, Yukio Tada, Rika Obata, Daisuke Yasuda, Kyoko Takahashi, Tsutomu Fujimura, Jingbo Pi, Myung-Shik Lee, Takashi Ueno, Tomoyuki Ohe, Tadahiko Mashino, Toshifumi Wakai, Hirotatsu Kojima, Takayoshi Okabe, Tetsuo Nagano, Hozumi Motohashi, Satoshi Waguri, Tomoyoshi Soga, Masayuki Yamamoto, Keiji Tanaka, Masaaki Komatsu
Publicado 2016

A pre-operative prognostic score for the selection of patients for salvage surgery after recurrent head and neck squamous cell carcinomas

por Valentina Lupato, Jerry Polesel, Fabio Biagio La Torre, Giuseppe Fanetti, Elisabetta Fratta, Carlo Gobitti, Gustavo Baldassarre, Emanuela Vaccher, Giovanni Franchin, Vittorio Giacomarra
Publicado 2021

Prognostic significance of pathologic nodal positivity in non-metastatic patients with renal cell carcinoma who underwent radical or partial nephrectomy

por Sung Han Kim, Boram Park, Eu Chang Hwang, Sung-Hoo Hong, Chang Wook Jeong, Cheol Kwak, Seok Soo Byun, Jinsoo Chung
Publicado 2021

A clinical scoring system for predicting tumor recurrence after percutaneous radiofrequency ablation for 3 cm or less hepatocellular carcinoma

por Yong Zhu He, Kun He, Rui Qin Huang, Li Wen Liu, Shao Wei Ye, Jun Lin Qian, Peng Peng, Qi Jie Luo, Ze Liang Wang, Ze Min Hu
Publicado 2021

Ability of artificial intelligence to detect T1 esophageal squamous cell carcinoma from endoscopic videos and the effects of real-time assistance

por Sho Shiroma, Toshiyuki Yoshio, Yusuke Kato, Yoshimasa Horie, Ken Namikawa, Yoshitaka Tokai, Shoichi Yoshimizu, Natsuko Yoshizawa, Yusuke Horiuchi, Akiyoshi Ishiyama, Toshiaki Hirasawa, Tomohiro Tsuchida, Naoki Akazawa, Junichi Akiyama, Tomohiro Tada, Junko Fujisaki
Publicado 2021

YIV-906 potentiated anti-PD1 action against hepatocellular carcinoma by enhancing adaptive and innate immunity in the tumor microenvironment

por Xiaochen Yang, Wing Lam, Zaoli Jiang, Fulan Guan, Xue Han, Rong Hu, Wei Cai, William Cheng, Shwu-Huey Liu, Peikwen Cheng, Yuping Cai, Nicholas J. W. Rattray, Caroline H. Johnson, Lieping Chen, Yung-Chi Cheng
Publicado 2021

A systematic review and meta-analysis of traditional insect Chinese medicines combined chemotherapy for non-surgical hepatocellular carcinoma therapy

por Zhaofeng Shi, Tiebing Song, Yi Wan, Juan Xie, Yiquan Yan, Kekai Shi, Yongping Du, Lei Shang
Publicado 2017

CircESRP1 inhibits clear cell renal cell carcinoma progression through the CTCF-mediated positive feedback loop

por Lin-Jing Gong, Xin-Yuan Wang, Xu-dong Yao, Xu Wu, Wen-Yu Gu
Publicado 2021

PD-1 inhibitors versus chemotherapy as second-line treatment for advanced esophageal squamous cell carcinoma: a meta-analysis

por Xinxin Zhu, Qiyue Shanzhou, Danyang Li, Xuezhou Pang, Daiyuan Ma
Publicado 2021

Sorafenib and triptolide loaded cancer cell-platelet hybrid membrane-camouflaged liquid crystalline lipid nanoparticles for the treatment of hepatocellular carcinoma

por Zhe Li, Gang Yang, Lu Han, Rong Wang, Chunai Gong, Yongfang Yuan
Publicado 2021

RET Proto-Oncogene Mutational Analysis in 45 Iranian Patients Affected with Medullary Thyroid Carcinoma: Report of a New Variant

por Elia Damavandi, Fatemeh Vand-Rajabpour, Maliheh Javadi-Arjmand, Mohammad-Reza Mohajeri Tehrani, Bagher Larijani, Majid Kabuli, Mohsen Ghadami
Publicado 2021

Development and Validation of a Nomogram Model to Predict Acute Kidney Disease After Nephrectomy in Patients with Renal Cell Carcinoma [Erratum]

por Hu XY, Liu DW, Qiao YJ, Zheng X, Duan JY, Pan SK, Liu ZS
Publicado 2021

Regulatory T-cells and associated pathways in metastatic renal cell carcinoma (mRCC) patients undergoing DC-vaccination and cytokine-therapy.

por Adrian Schwarzer, Benita Wolf, Jan L Fisher, Thomas Schwaab, Sven Olek, Udo Baron, Craig R Tomlinson, John D Seigne, Nancy A Crosby, Jiang Gui, Thomas H Hampton, Camilo E Fadul, John A Heaney, Marc S Ernstoff
Publicado 2012

Identification of a Six-Gene Prognostic Signature Characterized by Tumor Microenvironment Immune Profiles in Clear Cell Renal Cell Carcinoma

por Lu Zhang, Jianlong Li, Mengzhao Zhang, Lu Wang, Tao Yang, Qiuya Shao, Xiao Liang, Minghai Ma, Nan Zhang, Minxuan Jing, Rundong Song, Jinhai Fan, Jinhai Fan
Publicado 2021

Molecular characteristics and metastasis predictor genes of triple-negative breast cancer: a clinical study of triple-negative breast carcinomas.

por Wen-Hung Kuo, Yao-Yin Chang, Liang-Chuan Lai, Mong-Hsun Tsai, Chuhsing Kate Hsiao, King-Jen Chang, Eric Y Chuang
Publicado 2012

Loss of the α2β1 integrin alters human papilloma virus-induced squamous carcinoma progression in vivo and in vitro.

por Thuy Tran, Brittney Barlow, Lynda O'Rear, Brenda Jarvis, Zhengzhi Li, Kent Dickeson, William Dupont, Mary Zutter
Publicado 2011